Coalition Enhances Capacity to Advance Personalized Medicine in US & Around the World With Addition of Board Members Representing Researchers, Patients, Industry
WASHINGTON
In a development that enhances the Personalized Medicine Coalition (PMC)’s capacity to promote the understanding and adoption of the technologies and treatments underpinning personalized medicine for the benefit of patients and health systems in the U.S. and around the world, the Coalition is pleased to announce that it has added Dr. Antonio L. Andreu, Scientific Director of the European Infrastructure for Translational Medicine (EATRIS), Dr. Lori Frank, a Senior Behavioral Scientist with the RAND Corporation who sits on the Medical, Scientific and Memory Screening Advisory Board of the Alzheimer’s Foundation of America (AFA), and Mr. Mark P. Stevenson, Executive Vice President and Chief Operating Officer of Thermo Fisher Scientific, to its multi-stakeholder board of directors.
Dr. Andreu, who began his career as a researcher specializing in the genetics and genomics of rare diseases, went on to create Spain’s national personalized medicine program during his tenure as Director of the Spanish national institute of health, called the Instituto de Salud Carlos III.
Dr. Frank brings a deep background in the patient advocacy community. As a member of AFA’s Medical, Scientific and Medical Screening Advisory Board, Dr. Frank offers expert insight on scientific issues surrounding Alzheimer’s disease and related dementias.
Mr. Stevenson, Executive Vice President and Chief Operating Officer at Thermo Fisher, helps lead the company’s global efforts to advance personalized medicine by supporting commercialization, evidence development and advocacy to help enable delivery of molecular diagnostics and targeted therapeutics from translational research into the clinic.
“As impactful champions for personalized medicine who each represent an important part of the international health care landscape, Dr. Andreu, Dr. Frank and Mr. Stevenson are well-positioned to help guide PMC’s global education and advocacy programs,” said PMC Board Chairman Dr. Stephen L. Eck, Chief Medical Officer, Immatics US.
About the Personalized Medicine Coalition:
The Personalized Medicine Coalition, representing innovators, scientists, patients, providers and payers, promotes the understanding and adoption of personalized medicine concepts, services and products to benefit patients and the health system.
